Bill Text: TX HB3482 | 2019-2020 | 86th Legislature | Introduced
Bill Title: Relating to the designation of centers of excellence for the early diagnosis and treatment of placental disorders.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2019-03-18 - Referred to Public Health [HB3482 Detail]
Download: Texas-2019-HB3482-Introduced.html
86R7807 JG-D | ||
By: Davis of Harris | H.B. No. 3482 |
|
||
|
||
relating to the designation of centers of excellence for the early | ||
diagnosis and treatment of placental disorders. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Chapter 32, Health and Safety Code, is amended by | ||
adding Subchapter E to read as follows: | ||
SUBCHAPTER E. CENTERS OF EXCELLENCE FOR EARLY DIAGNOSIS AND | ||
TREATMENT OF PLACENTAL DISORDERS | ||
Sec. 32.101. DEFINITION. In this subchapter, "placental | ||
disorder" includes placenta accreta, placenta increta, and | ||
placenta percreta. | ||
Sec. 32.102. DESIGNATION OF CENTERS OF EXCELLENCE. (a) The | ||
department, in consultation with the maternal mortality and | ||
morbidity task force established under Chapter 34, shall designate | ||
as centers of excellence for the early diagnosis and treatment of | ||
placental disorders one or more health care entities or programs in | ||
this state, including institutions of higher education or programs | ||
of those institutions. | ||
(b) The executive commissioner, in consultation with the | ||
department and the maternal mortality and morbidity task force, | ||
shall adopt rules necessary for a health care entity or program in | ||
this state to be designated as a center of excellence for early | ||
diagnosis and treatment of placental disorders. | ||
Sec. 32.103. SUBCOMMITTEE. (a) The department, in | ||
consultation with the maternal mortality and morbidity task force, | ||
shall appoint a subcommittee of the task force to advise the | ||
executive commissioner on the adoption of rules under Section | ||
32.102. As part of the subcommittee's duties under this | ||
subsection, the subcommittee specifically shall advise the | ||
executive commissioner on the criteria necessary for a health care | ||
entity or program in this state to receive a designation under this | ||
subchapter. | ||
(b) The subcommittee must consist of individuals with | ||
expertise in the early diagnosis and treatment of placental | ||
disorders. A majority of the members of the subcommittee must | ||
practice in those areas in a health profession in this state. The | ||
subcommittee may include national and international experts. | ||
Sec. 32.104. PRIORITY CONSIDERATIONS FOR CENTER | ||
DESIGNATIONS. The rules adopted under Section 32.102 must | ||
prioritize awarding a designation under this subchapter to a health | ||
care entity or program that: | ||
(1) offers early diagnosis and treatment services for | ||
placental disorders through a multi-specialty clinical program | ||
that is affiliated and collaborates extensively with a medical | ||
school in this state and an associated hospital that provides | ||
advanced maternal and neonatal care in accordance with the | ||
hospital's level of care designation received under Section | ||
241.182; | ||
(2) demonstrates a significant commitment to research | ||
in and advancing the field of placental disorder care; | ||
(3) offers advanced training programs in the early | ||
diagnosis and treatment of placental disorders; and | ||
(4) integrates an advanced placental disorder care | ||
program with a program that provides appropriate long-term | ||
monitoring and follow-up care for patients. | ||
Sec. 32.105. REQUIREMENTS FOR DESIGNATION. The rules | ||
adopted under Section 32.102 must ensure that a health care entity | ||
or program in this state that receives a center of excellence | ||
designation under this subchapter: | ||
(1) provides or is affiliated with a hospital that | ||
provides advanced maternal and neonatal care in accordance with the | ||
hospital's level of care designation received under Section | ||
241.182; | ||
(2) implements and maintains a multidisciplinary | ||
health care team, including maternal fetal medicine specialists, | ||
pediatric and surgical specialists, neonatologists, nurses with | ||
specialized maternal and neonatal training, and other ancillary and | ||
support staff as appropriate to provide care related to placental | ||
disorders; | ||
(3) establishes minimum criteria for medical staff, | ||
nursing staff, and ancillary and support staff; | ||
(4) measures short-term and long-term patient | ||
diagnostic and therapeutic outcomes; and | ||
(5) provides to the department annual reports | ||
containing aggregate data on short-term and long-term diagnostic | ||
and therapeutic outcomes as requested or required by the department | ||
and makes those reports available to the public on the entity's or | ||
program's Internet website. | ||
SECTION 2. (a) Not later than December 1, 2019, the | ||
Department of State Health Services, in consultation with the | ||
maternal mortality and morbidity task force established under | ||
Chapter 34, Health and Safety Code, shall appoint members to the | ||
subcommittee as required by Section 32.103, Health and Safety Code, | ||
as added by this Act. | ||
(b) Not later than December 1, 2020, the executive | ||
commissioner of the Health and Human Services Commission shall | ||
adopt rules as required by Section 32.102, Health and Safety Code, | ||
as added by this Act. | ||
(c) Not later than September 1, 2021, the Department of | ||
State Health Services shall begin awarding designations of centers | ||
of excellence as required by Subchapter E, Chapter 32, Health and | ||
Safety Code, as added by this Act. | ||
SECTION 3. This Act takes effect September 1, 2019. |